Homeopathy and women's diseases

Treatment of pain due to unwanted lactation with a homeopathic preparation given in the immediate post-partum period - Fédération de Gynécologie-Obstétrique, Service de Pharmacie, CHU La Grave, Toulouse, France

Results: A significant improvement of lactation pain (main criterion of the study) was observed in parturients treated with homeopathy (p<0.02 on D2 and p<0.01 on D4). A similar effect (p<0.05 on D4) was observed for breast tension and spontaneous milk flow... READ MORE

Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial - Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA

Results: A statistically significant improvement in general health score in both homeopathy groups (p < 0.05) on the SF-36 after 1 year was found.... Evidence of a homeopathic "drug proving" in the subjects receiving the homeopathic combination medicine who were not taking tamoxifen also was found. Small sample size precludes definitive answers, but results from this preliminary trial suggest that homeopathy may be of value in the treatment of menopausal symptoms and improving quality of life, especially in those women not on tamoxifen. READ MORE

Results: 18 consecutive cases of secondary amenorrhea (SA) and oligomenorrhea (OL) met the entry criteria. 8 women had SA, 2 were on HRT, 6 had OL-AM and 2 had OL. The average duration of considered follow-up was 21 months. The average time before the reappearance of menstruation was 58 days (s.d. 20) in the 8 women with SA at the time of the first appointment, for all cases 46 days (s.d. 42). Change of clinical diagnosis: 50% of women, who were diagnosed AM, recovered their ovulatory cycle (OV), whereas 12.5% remained amenorrheic; 33.3% of patients, who were initially OL-AM, showed an OV; 100% of oligomenorrheic and HRT patients recovered an OV. READ MORE

Homeopathic treatment of patients with dysmenorrhea: a prospective observational study with 2 years follow-up - Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, Germany.